CA125 nadir values as a prognostic factor in epithelial ovarian cancer

被引：5
|
作者：
Pignata, S [1 ]
Perrone, F
Di Maio, M
Gallo, C
De Placido, S
机构：
[1] Natl Canc Inst, Naples, Italy
[2] Univ Naples 2, Dept Med Stat, Naples, Italy
[3] Univ Naples Federico II, Dept Med Oncol, Naples, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 10期
关键词：
D O I：
10.1200/JCO.2005.05.266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2436 / 2437
页数：2
相关论文
共 50 条
  • [21] Potential markers that complement expression of CA125 in epithelial ovarian cancer
    Rosen, DG
    Wang, L
    Atkinson, JN
    Yu, YH
    Lu, KH
    Diamandis, EP
    Hellstrom, I
    Mok, SC
    Liu, JS
    Bast, RC
    GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 267 - 277
  • [22] CA125 PARAMETERS IN SURVIVORS AND NONSURVIVORS WITH EPITHELIAL OVARIAN-CANCER
    CRUICKSHANK, DJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (06) : 279 - 284
  • [23] Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer
    Tang, Ying
    Hu, Hui-quan
    Tang, Fang-xiang
    Lin, Dan
    Shen, Rui
    Deng, Li
    Tang, Ya-lan
    Deng, Li-hong
    Zhou, Mi
    Li, Jun
    Su, Bin
    Xu, Fan
    JOURNAL OF CANCER, 2020, 11 (11): : 3165 - 3171
  • [24] A CA125 SCORE AS A PROGNOSTIC INDEX IN PATIENTS WITH OVARIAN-CANCER
    ROSEN, A
    SEVELDA, P
    KLEIN, M
    SPONA, J
    BECK, A
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1990, 247 (03) : 125 - 129
  • [25] PERIOPERATIVE CHANGE IN CA125 IS AN INDEPENDENT PROGNOSTIC FACTOR FOR IMPROVED CLINICAL OUTCOME IN ADVANCED OVARIAN CANCER
    Timmermans, M.
    Zwakman, N.
    Sonke, G. S.
    Van de Vijver, K. K.
    Duk, J. M.
    van der Aa, M. A.
    Kruitwagen, R. F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 854 - 854
  • [26] THE PROGNOSTIC VALUE OF EARLY CA125 SERUM ASSAY IN EPITHELIAL OVARIAN-CARCINOMA
    FISKEN, J
    LEONARD, RCF
    STEWART, M
    BEATTIE, GJ
    STURGEON, C
    ASPINALL, L
    ROULSTON, JE
    BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 140 - 145
  • [27] Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer
    Timmermans, M.
    Zwakman, N.
    Sonke, G. S.
    Van de Vijver, K. K.
    Duk, M. J.
    van der Aa, M. A.
    Kruitwagen, R. F.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 240 : 364 - 369
  • [28] Epithelial ovarian tumors and CA125 in premenarchal girls
    Stankovic, Z.
    Djuricic, S.
    Djukic, M.
    Jovanovic, D.
    Vasiljevic, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (06) : 597 - 599
  • [29] The predictive and prognostic value of serum CA125 kinetics and CA125 nadir during paclitaxel/platinum based chemotherapy (QT) in patients with advanced ovarian carcinoma (OC)
    Tibau, A.
    Ojeda, M. B.
    Nadal, R. M.
    Gallardo, A.
    Perez Altozano, J.
    Sala, N.
    Mazarico, J. M.
    Boguna, I.
    Artigas, V.
    Barnadas, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 457 - 457
  • [30] CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations
    Cramer, Daniel W.
    O'Rourke, Dennis J.
    Vitonis, Allison F.
    Matulonis, Ursula A.
    DiJohn-son, Daniel A.
    Sluss, Patrick M.
    Crum, Christopher P.
    Liu, Brian C. -S.
    CLINICAL CHEMISTRY, 2010, 56 (12) : 1889 - 1892
12345